Iżrael - Ingliż - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - exemestane - coated tablets - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.

Belġju - Ingliż - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - exemestane 25 mg - film-coated tablet - 25 mg - exemestane 25 mg - exemestane

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - exemestane -

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - exemestane, quantity: 25 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; sodium starch glycollate type a; hypromellose; mannitol; microcrystalline cellulose; magnesium stearate; crospovidone; polysorbate 80; titanium dioxide; macrogol 400 - exemestane is indicated for the sequential adjuvant treatment of oestrogen receptor-positive early breast cancer in post-menopausal women who have received prior adjuvant tamoxifen therapy. . exemestane is indicated for the treatment of oestrogen receptor-positive advanced breast cancer in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy.

Belġju - Ingliż - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

accord healthcare b.v. - exemestane 25 mg - film-coated tablet - 25 mg - exemestane 25 mg - exemestane

Belġju - Ingliż - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

teva pharma belgium sa-nv - exemestane 25 mg - film-coated tablet - 25 mg - exemestane 25 mg - exemestane

Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - exemestane -

Irlanda - Ingliż - HPRA (Health Products Regulatory Authority)

helm ag - exemestane - coated tablets - 25 milligram

Kanada - Ingliż - Health Canada

teva canada limited - exemestane - tablet - 25mg - exemestane 25mg - antineoplastic agents

Kanada - Ingliż - Health Canada

apotex inc - exemestane - tablet - 25mg - exemestane 25mg - antineoplastic agents